-
10821
-
10822
Diagnosis and Treatment of Patients with Autoimmune Hepatitis (Experts’ Agreement)
Published 2025-02-01Get full text
Article -
10823
-
10824
-
10825
-
10826
-
10827
-
10828
-
10829
-
10830
Harnessing genomic and bioinformatic data to broaden understanding of leukaemia across continents
Published 2024-01-01“…Methods: This study used genome-wide association study (GWAS) data obtained from the National Human Genome Research Institute (NHGRI) to search for genomic variants associated with leukaemia. …”
Get full text
Article -
10831
-
10832
برآورد و ارزیابی مولفههای بیلان آب با واسنجی مدل SWAT، مطالعه موردی: دشت مهاباد
Published 2023-03-01Get full text
Article -
10833
Geospatial Access to Emergency Obstetric Surgery in Indonesia: Is Travel Time for Access Too Long?
Published 2024-12-01Get full text
Article -
10834
-
10835
-
10836
-
10837
-
10838
-
10839
Novel complex medication containing medium chain triglycerides for the treatment of dry eye
Published 2024-06-01“…Polyakov<sup>3</sup> </p> <p> <sup>1</sup>M.M. Krasnov Research Institute of Eye Diseases, Moscow, Russian Federation </p> <p> <sup>2</sup>V.I. …”
Get full text
Article -
10840
Utility of 131I-HLX58-Der for the Precision Treatment: Evaluation of a Preclinical Radio-Antibody-Drug-Conjugate Approach in Mouse Models
Published 2025-01-01“…Yi Liu,1– 4,* Xiao Wang,1– 3,5,* Ni Zhang,1– 4,* Simin He,1– 4 Jianping Zhang,1– 4 Xiaoping Xu,1– 4 Shaoli Song1– 4 1Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China; 2Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China; 3Center for Biomedical Imaging, Fudan University, Shanghai, 200032, People’s Republic of China; 4Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, 200032, People’s Republic of China; 5State Key Laboratory of Vaccines for Infectious Diseases, Xiang an Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, People’s Republic of China*These authors contributed equally to this workCorrespondence: Shaoli Song; Xiaoping Xu, Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, 200032, People’s Republic of China, Email shaoli-song@163.com; xxp0012@ustc.eduPurpose: None of the antibody-drug conjugates (ADCs) targeting Claudin 18.2 (CLDN18.2) have received approval from regulatory authorities due to their limited clinical benefits. …”
Get full text
Article